Century Therapeutics, Inc. (IPSC)

2.02 -9.19% (-0.21)

Over 6M: -10.4%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 2.5 3
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -25.8M Q3 '21 — Free Cash Flow: -39.7M Q4 '21 — Operating Income: -28M Q4 '21 — Free Cash Flow: -41.1M Q1 '22 — Operating Income: -37.4M Q1 '22 — Free Cash Flow: 82.7M Q2 '22 — Operating Income: -31.4M Q2 '22 — Free Cash Flow: -36M Q3 '22 — Operating Income: -31.7M Q3 '22 — Free Cash Flow: -34M Q4 '22 — Operating Income: -33.3M Q4 '22 — Free Cash Flow: -29.2M Q1 '23 — Operating Income: -32.1M Q1 '23 — Free Cash Flow: -34.2M Q2 '23 — Operating Income: -35.1M Q2 '23 — Free Cash Flow: -23.8M Q3 '23 — Operating Income: -35.6M Q3 '23 — Free Cash Flow: -16.9M Q4 '23 — Operating Income: -43.8M Q4 '23 — Free Cash Flow: -27.2M Q1 '24 — Operating Income: -31.3M Q1 '24 — Free Cash Flow: -30.8M Q2 '24 — Operating Income: -34.8M Q2 '24 — Free Cash Flow: -27.6M Q3 '24 — Operating Income: -34.8M Q4 '24 — Operating Income: -37.3M Q1 '25 — Operating Income: 74.2M Q1 '25 — Free Cash Flow: -35.1M Q2 '25 — Operating Income: -34.7M Q2 '25 — Free Cash Flow: -27.9M Q3 '25 — Operating Income: -36.1M Q3 '25 — Free Cash Flow: -25.8M Q4 '25 — Operating Income: -20.7M Q1 '26 — Operating Income: -23.7M Q1 '26 — Free Cash Flow: -25.8M Q2 '26 — Operating Income: -36.5M Q2 '26 — Free Cash Flow: -20.5M -30M 0 30M 60M 90M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Income Free Cash Flow

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.1
OE margin -85.4%
Oper. margin -107.2%
ROIC -82.1%
Accruals -8.0%
EBITDA margin -98.3%
FCF margin -80.3%
OCF margin -79.5%
Profit margin -100.6%
ROA -38.3%
ROCE -43.0%
ROE -47.3%
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 1.0×
RPO growth -0.011%
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA —
Cash runway 1.4 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 8.3×
F-score 3.9 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.6
Sales/sh Y/Y +1405.1%
Shares change +10.1%
Sales Q/Q -100.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.